Both in Pharmaceuticals
Rallybio vs Milestone Pharmaceuticals
Over the past year RLYB returned +190.7% and MIST returned −60.5%; their daily moves had a correlation of 0.08.
RLYB +190.7% MIST −60.5%Growth of $1, one year, split-adjusted
| Metric | RLYB | MIST |
|---|---|---|
| Price | $15.54 | $0.7300 |
| Market cap | $83.7M | $90.9M |
| Today | +0.84% | −7.55% |
| 1 month | −7.3% | −10.5% |
| 6 months | +65.1% | −61.0% |
| Year to date | +183.1% | −63.9% |
| 1 year | +220.9% | −60.3% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | 94.3% |
| Net margin | — | −5118.8% |
| P/E (TTM) | 3.1× | — |
| Price / sales | 192.8× | 38.8× |
| Net cash | $90.7M | $111.4M |
| Dividend yield | — | — |
| Volatility (60d) | 24.4% | 74.0% |
| Short % of float | 1.6% | 17.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).